| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.672 | 15.587 | 18.750 | 18.975 | 25.288 | 25.291 | 29.588 | 31.551 | 32.126 | 35.897 |
| Total Income - EUR | 22.672 | 15.587 | 18.750 | 18.975 | 25.288 | 25.291 | 29.588 | 35.736 | 32.155 | 35.897 |
| Total Expenses - EUR | 22.008 | 17.757 | 18.717 | 12.198 | 10.605 | 9.178 | 10.099 | 15.675 | 11.253 | 13.947 |
| Gross Profit/Loss - EUR | 664 | -2.170 | 33 | 6.776 | 14.682 | 16.113 | 19.489 | 20.061 | 20.902 | 21.950 |
| Net Profit/Loss - EUR | -16 | -2.637 | -961 | 6.587 | 14.430 | 15.879 | 19.193 | 19.793 | 20.587 | 21.599 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Win Pharmarom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.438 | 9.172 | 92 | 0 | 0 | 0 | 390 | 245 | 97 | 0 |
| Current Assets | 34.961 | 42.025 | 17.453 | 9.043 | 23.438 | 17.662 | 21.228 | 24.387 | 42.432 | 23.900 |
| Inventories | 295 | 292 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 418 |
| Receivables | 22.703 | 23.578 | 10.291 | 2.207 | 2.514 | 2.467 | 15.829 | 18.736 | 18.490 | 19.584 |
| Cash | 11.962 | 18.154 | 7.162 | 6.836 | 20.924 | 15.195 | 5.400 | 5.651 | 23.941 | 3.898 |
| Shareholders Funds | 29.304 | 26.368 | 881 | 7.452 | 21.737 | 15.913 | 9.218 | 19.854 | 40.380 | 21.659 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.418 | 24.974 | 16.791 | 1.591 | 1.800 | 1.749 | 12.400 | 4.778 | 2.149 | 2.241 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Win Pharmarom Srl